Induction and expression of ßig-h3 in pancreatic cancer cells

Dominik Schneider, Jörg Kleeff, Pascal O. Berberat, Zhaowen Zhu, Murray Korc, Helmut Friess, Markus W. Büchler

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

ßig-h3 (TGFBI, keratoepithelin) was first identified as a transforming growth factor-β1 (TGF-β1)-inducible gene in a human lung adenocarcinoma cell line. It encodes for a secreted extracellular matrix (ECM) protein, which is thought to act on cell attachment and ECM composition. Mutations of the ßig-h3 gene are involved in several corneal dystrophies. Pancreatic cancers display multiple alterations in the TGF-β signaling pathway and in TGF-β response genes, such as overexpression of all three TGF-β isoforms and Smad4 mutations. In this report, we determined that ßig-h3 mRNA levels were induced by TGF-β1 in two out of five examined pancreatic cancer cell lines (CAPAN-1, PANC-1). In CAPAN-1 cells, which harbor a Smad4 mutation, ßig-h3 but not PAI-1 was induced by TGF-β1, whereas in PANC-1 cells that express wild-type Smad4, TGF-β1 induced both PAI-1 and ßig-h3. In human pancreatic tissues, there was a 32.4-fold increase in ßig-h3 mRNA levels in pancreatic cancers in comparison to normal control tissues. In situ hybridization analysis revealed that ßig-h3 mRNA was expressed mainly in the cancer cells within the pancreatic tumor mass. These findings suggest that ßig-h3 is induced by TGF-βs in pancreatic cancer cells even in the presence of Smad4 mutations, which might explain, in part, the increased ßig-h3 mRNA levels observed in pancreatic cancer cells in vivo.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1588
Issue number1
DOIs
StatePublished - Oct 9 2002
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Transforming Growth Factors
Messenger RNA
Mutation
Plasminogen Activator Inhibitor 1
Cell Line
Immunoglobulin Genes
Extracellular Matrix Proteins
Genes
In Situ Hybridization
Extracellular Matrix
Neoplasms
Protein Isoforms

Keywords

  • ßig-h3
  • PAI-1
  • Pancreatic cancer
  • SMAD4
  • TGF-β

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Biophysics

Cite this

Schneider, D., Kleeff, J., Berberat, P. O., Zhu, Z., Korc, M., Friess, H., & Büchler, M. W. (2002). Induction and expression of ßig-h3 in pancreatic cancer cells. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1588(1), 1-6. https://doi.org/10.1016/S0925-4439(02)00052-2

Induction and expression of ßig-h3 in pancreatic cancer cells. / Schneider, Dominik; Kleeff, Jörg; Berberat, Pascal O.; Zhu, Zhaowen; Korc, Murray; Friess, Helmut; Büchler, Markus W.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1588, No. 1, 09.10.2002, p. 1-6.

Research output: Contribution to journalArticle

Schneider, D, Kleeff, J, Berberat, PO, Zhu, Z, Korc, M, Friess, H & Büchler, MW 2002, 'Induction and expression of ßig-h3 in pancreatic cancer cells', Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1588, no. 1, pp. 1-6. https://doi.org/10.1016/S0925-4439(02)00052-2
Schneider, Dominik ; Kleeff, Jörg ; Berberat, Pascal O. ; Zhu, Zhaowen ; Korc, Murray ; Friess, Helmut ; Büchler, Markus W. / Induction and expression of ßig-h3 in pancreatic cancer cells. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2002 ; Vol. 1588, No. 1. pp. 1-6.
@article{68cca4eb705240c0b34c309d61750b40,
title = "Induction and expression of {\ss}ig-h3 in pancreatic cancer cells",
abstract = "{\ss}ig-h3 (TGFBI, keratoepithelin) was first identified as a transforming growth factor-β1 (TGF-β1)-inducible gene in a human lung adenocarcinoma cell line. It encodes for a secreted extracellular matrix (ECM) protein, which is thought to act on cell attachment and ECM composition. Mutations of the {\ss}ig-h3 gene are involved in several corneal dystrophies. Pancreatic cancers display multiple alterations in the TGF-β signaling pathway and in TGF-β response genes, such as overexpression of all three TGF-β isoforms and Smad4 mutations. In this report, we determined that {\ss}ig-h3 mRNA levels were induced by TGF-β1 in two out of five examined pancreatic cancer cell lines (CAPAN-1, PANC-1). In CAPAN-1 cells, which harbor a Smad4 mutation, {\ss}ig-h3 but not PAI-1 was induced by TGF-β1, whereas in PANC-1 cells that express wild-type Smad4, TGF-β1 induced both PAI-1 and {\ss}ig-h3. In human pancreatic tissues, there was a 32.4-fold increase in {\ss}ig-h3 mRNA levels in pancreatic cancers in comparison to normal control tissues. In situ hybridization analysis revealed that {\ss}ig-h3 mRNA was expressed mainly in the cancer cells within the pancreatic tumor mass. These findings suggest that {\ss}ig-h3 is induced by TGF-βs in pancreatic cancer cells even in the presence of Smad4 mutations, which might explain, in part, the increased {\ss}ig-h3 mRNA levels observed in pancreatic cancer cells in vivo.",
keywords = "{\ss}ig-h3, PAI-1, Pancreatic cancer, SMAD4, TGF-β",
author = "Dominik Schneider and J{\"o}rg Kleeff and Berberat, {Pascal O.} and Zhaowen Zhu and Murray Korc and Helmut Friess and B{\"u}chler, {Markus W.}",
year = "2002",
month = "10",
day = "9",
doi = "10.1016/S0925-4439(02)00052-2",
language = "English (US)",
volume = "1588",
pages = "1--6",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Induction and expression of ßig-h3 in pancreatic cancer cells

AU - Schneider, Dominik

AU - Kleeff, Jörg

AU - Berberat, Pascal O.

AU - Zhu, Zhaowen

AU - Korc, Murray

AU - Friess, Helmut

AU - Büchler, Markus W.

PY - 2002/10/9

Y1 - 2002/10/9

N2 - ßig-h3 (TGFBI, keratoepithelin) was first identified as a transforming growth factor-β1 (TGF-β1)-inducible gene in a human lung adenocarcinoma cell line. It encodes for a secreted extracellular matrix (ECM) protein, which is thought to act on cell attachment and ECM composition. Mutations of the ßig-h3 gene are involved in several corneal dystrophies. Pancreatic cancers display multiple alterations in the TGF-β signaling pathway and in TGF-β response genes, such as overexpression of all three TGF-β isoforms and Smad4 mutations. In this report, we determined that ßig-h3 mRNA levels were induced by TGF-β1 in two out of five examined pancreatic cancer cell lines (CAPAN-1, PANC-1). In CAPAN-1 cells, which harbor a Smad4 mutation, ßig-h3 but not PAI-1 was induced by TGF-β1, whereas in PANC-1 cells that express wild-type Smad4, TGF-β1 induced both PAI-1 and ßig-h3. In human pancreatic tissues, there was a 32.4-fold increase in ßig-h3 mRNA levels in pancreatic cancers in comparison to normal control tissues. In situ hybridization analysis revealed that ßig-h3 mRNA was expressed mainly in the cancer cells within the pancreatic tumor mass. These findings suggest that ßig-h3 is induced by TGF-βs in pancreatic cancer cells even in the presence of Smad4 mutations, which might explain, in part, the increased ßig-h3 mRNA levels observed in pancreatic cancer cells in vivo.

AB - ßig-h3 (TGFBI, keratoepithelin) was first identified as a transforming growth factor-β1 (TGF-β1)-inducible gene in a human lung adenocarcinoma cell line. It encodes for a secreted extracellular matrix (ECM) protein, which is thought to act on cell attachment and ECM composition. Mutations of the ßig-h3 gene are involved in several corneal dystrophies. Pancreatic cancers display multiple alterations in the TGF-β signaling pathway and in TGF-β response genes, such as overexpression of all three TGF-β isoforms and Smad4 mutations. In this report, we determined that ßig-h3 mRNA levels were induced by TGF-β1 in two out of five examined pancreatic cancer cell lines (CAPAN-1, PANC-1). In CAPAN-1 cells, which harbor a Smad4 mutation, ßig-h3 but not PAI-1 was induced by TGF-β1, whereas in PANC-1 cells that express wild-type Smad4, TGF-β1 induced both PAI-1 and ßig-h3. In human pancreatic tissues, there was a 32.4-fold increase in ßig-h3 mRNA levels in pancreatic cancers in comparison to normal control tissues. In situ hybridization analysis revealed that ßig-h3 mRNA was expressed mainly in the cancer cells within the pancreatic tumor mass. These findings suggest that ßig-h3 is induced by TGF-βs in pancreatic cancer cells even in the presence of Smad4 mutations, which might explain, in part, the increased ßig-h3 mRNA levels observed in pancreatic cancer cells in vivo.

KW - ßig-h3

KW - PAI-1

KW - Pancreatic cancer

KW - SMAD4

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=0037048541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037048541&partnerID=8YFLogxK

U2 - 10.1016/S0925-4439(02)00052-2

DO - 10.1016/S0925-4439(02)00052-2

M3 - Article

C2 - 12379307

AN - SCOPUS:0037048541

VL - 1588

SP - 1

EP - 6

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 1

ER -